NASDAQ
BCPC

Balchem Corporation

Specialty Chemicals
Basic Materials

Prices are adjusted according to historical splits.

Balchem Corporation Stock Price

Vitals

Today's Low:
$130.535
Today's High:
$132.11
Open Price:
$132.1
52W Low:
$109.5042
52W High:
$143.0422
Prev. Close:
$132.28
Volume:
74770

Company Statistics

Market Cap.:
$4.16 billion
Book Value:
30.206
Revenue TTM:
$946.03 million
Operating Margin TTM:
15.1%
Gross Profit TTM:
$280.45 million
Profit Margin:
10.48%
Return on Assets TTM:
6.32%
Return on Equity TTM:
10.74%

Company Profile

Balchem Corporation had its IPO on 1986-06-03 under the ticker symbol BCPC.

The company operates in the Basic Materials sector and Specialty Chemicals industry. Balchem Corporation has a staff strength of 1,331 employees.

Stock update

Shares of Balchem Corporation opened at $132.1 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $130.54 - $132.11, and closed at $131.36.

This is a -0.7% slip from the previous day's closing price.

A total volume of 74,770 shares were traded at the close of the day’s session.

In the last one week, shares of Balchem Corporation have slipped by -6.57%.

Balchem Corporation's Key Ratios

Balchem Corporation has a market cap of $4.16 billion, indicating a price to book ratio of 4.6335 and a price to sales ratio of 4.2718.

In the last 12-months Balchem Corporation’s revenue was $946.03 million with a gross profit of $280.45 million and an EBITDA of $196.09 million. The EBITDA ratio measures Balchem Corporation's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Balchem Corporation’s operating margin was 15.1% while its return on assets stood at 6.32% with a return of equity of 10.74%.

In Q1, Balchem Corporation’s quarterly earnings growth was a negative -21.3% while revenue growth was a positive 1.6%.

Balchem Corporation’s PE and PEG Ratio

Forward PE
31.5457
Trailing PE
42.1994
PEG
8.2908

Its diluted EPS in the last 12-months stands at $3.06 per share while it has a forward price to earnings multiple of 31.5457 and a PEG multiple of 8.2908. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Balchem Corporation’s profitability.

Balchem Corporation stock is trading at a EV to sales ratio of 4.953 and a EV to EBITDA ratio of 23.1996. Its price to sales ratio in the trailing 12-months stood at 4.2718.

Balchem Corporation stock pays annual dividends of $0.71 per share, indicating a yield of 0.55% and a payout ratio of 17.97%.

Balance sheet and cash flow metrics

Total Assets
$52.10 million
Total Liabilities
$5.19 million
Operating Cash Flow
$-10061000.00
Capital Expenditure
$895000
Dividend Payout Ratio
17.97%

Balchem Corporation ended 2024 with $52.10 million in total assets and $0 in total liabilities. Its intangible assets were valued at $52.10 million while shareholder equity stood at $35.18 million.

Balchem Corporation ended 2024 with $62.92 million in deferred long-term liabilities, $5.19 million in other current liabilities, 327000.00 in common stock, $32.49 million in retained earnings and $6.37 million in goodwill. Its cash balance stood at $1.81 million and cash and short-term investments were $1.81 million. The company’s total short-term debt was $1,742,000 while long-term debt stood at $460.66 million.

Balchem Corporation’s total current assets stands at $17.58 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $7.30 million compared to accounts payable of $2.91 million and inventory worth $7.00 million.

In 2024, Balchem Corporation's operating cash flow was $-10061000.00 while its capital expenditure stood at $895000.

Comparatively, Balchem Corporation paid $0.18 in dividends in 2024.

Other key metrics

Current Trading Price
$131.36
52-Week High
$143.0422
52-Week Low
$109.5042
Analyst Target Price
$150

Balchem Corporation stock is currently trading at $131.36 per share. It touched a 52-week high of $143.0422 and a 52-week low of $143.0422. Analysts tracking the stock have a 12-month average target price of $150.

Its 50-day moving average was $134.1 and 200-day moving average was $130.28 The short ratio stood at 4.19 indicating a short percent outstanding of 0%.

Around 93.1% of the company’s stock are held by insiders while 9163.4% are held by institutions.

Frequently Asked Questions About Balchem Corporation

The stock symbol (also called stock or share ticker) of Balchem Corporation is BCPC

The IPO of Balchem Corporation took place on 1986-06-03

Similar Industry Stocks (Specialty Chemicals)

Last Price
Chg
Chg%
$9.12
-0.48
-5%
$387.15
-5.85
-1.49%
$81.57
-5.3
-6.1%
$125.51
-0.88
-0.7%
$2.66
-0.1
-3.62%
$10.16
-0.31
-2.95%
$3.36
0
0%
Mrc Exim Ltd. (540809)
$15.52
-0.31
-1.96%
$0.48
-0.07
-13.13%
$584.55
-43.45
-6.92%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; single use canisters for sterilizing re-usable devices; and ammonia. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in Montvale, New Jersey.

Address

52 Sunrise Park Road, New Hampton, NY, United States, 10958